Bundamedik Tbk PT (BMHS) — Capital Reinvestment Ratio
Latest as of December 2025:
0.58x
Bundamedik Tbk PT (BMHS) has a Capital Reinvestment Ratio of 0.58x as of December 2025, meaning it reinvests 1% of its operating cash flow (Rp199.64 Billion) in capital expenditures (Rp116.26 Billion). See Bundamedik Tbk PT (BMHS) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.58x
Capex / Operating Cash Flow
Operating Cash Flow
Rp199.64 Billion
IDR
Capital Expenditures
Rp116.26 Billion
IDR
Data as of
Dec 2025
Most recent filing
Bundamedik Tbk PT Capital Reinvestment Ratio (2018–2025)
This chart tracks Bundamedik Tbk PT's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Bundamedik Tbk PT (2018–2025)
Year-by-year Capital Reinvestment Ratio for Bundamedik Tbk PT from 2018 to 2025. For live market cap and broader valuation context, see Bundamedik Tbk PT market capitalisation.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.87x | Rp250.62 Billion | Rp218.91 Billion | ▼ -87.4% |
| 2024 | 6.95x | Rp33.98 Billion | Rp236.03 Billion | ▲ +70.7% |
| 2023 | 4.07x | Rp51.44 Billion | Rp209.35 Billion | ▲ +220.3% |
| 2022 | 1.27x | Rp237.47 Billion | Rp301.73 Billion | ▲ +94.7% |
| 2021 | 0.65x | Rp349.44 Billion | Rp228.08 Billion | ▲ +150.5% |
| 2020 | 0.26x | Rp190.36 Billion | Rp49.61 Billion | ▼ -67.8% |
| 2019 | 0.81x | Rp89.72 Billion | Rp72.50 Billion | ▼ -77.4% |
| 2018 | 3.57x | Rp43.79 Billion | Rp156.54 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow